| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |